α1-adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: Involvement of p38 mitogen-activated protein kinase and nuclear factor-κB

Molecular Pharmacology

Volumn 76, Issue 1, 2009, Pages 144-152

  Perez, Dianne M ^a   Papay, Robert S ^a   Shi, Ting ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBROBLAST; GENE CONSTRUCT; GENE DELETION; GENETIC TRANSFECTION; HEART MUSCLE CELL; MODULATION; MOLECULAR MECHANICS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RNA STABILITY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; BLOOD; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MICE; MYOCYTES, CARDIAC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; RNA STABILITY; TRANSCRIPTION, GENETIC;

EID: 67649836758     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.054320     Document Type: Article

References (40)

1. Briest W, Rassler B, Deten A, Leicht M, Morwinski R, Neichel D, Wallukat G, Ziegelhöffer T, and Zimmer HG (2003) Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and nonmyocytes. Pflugers Arch 446:437-446. (Pubitemid 36920936)
2. Bürger A, Benicke M, Deten A, and Zimmer HG (2001) Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol 281:H14-H21.
3. Chen CY and Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20:465-470.
4. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, and Glembotski CC (2000) p38 MAPK and NF-κB collaborate to induce interleukin-6 gene expression and release. J Biol Chem 275:23814-23824.
5. Davies SP, Reddy H, Caivano M, and Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105. (Pubitemid 30781561)
6. Franchimont N, Rydziel S, and Canalis E (1997) Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest 100:1797-1803. (Pubitemid 27431338)
7. Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, Ross SA, Papay RS, McCune DF, Rorabaugh BR, and Perez DM (2003) Genetic profiling of α1-adrenergic receptor subtypes by oligonucleotide microarrays: coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. Mol Pharmacol 63:1104-1116. (Pubitemid 36529929)
8. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, Müller W, and Chien KR (1999) Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97:189-198. (Pubitemid 29194270)
9. Hirota H, Yoshida K, Kishimoto T, and Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for IL-6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A 92:4862-4866.
10. Huang Y, Wright CD, Merkwan CL, Baye NL, Liang Q, Simpson PC, and O'Connell TD (2007) An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 115:763-772. (Pubitemid 46294744)
11. Kanda T, Inoue M, Kotajima N, Fujimaki S, Hoshino Y, Kurabayashi M, Kobayashi I, and Tamura J (2000) Circulating IL-6 and IL-6 receptors in patients with acute and recent myocardial infarction. Cardiology 93:191-196. (Pubitemid 30759260)
12. Kobayashi S, Nagino M, Komatsu S, Naruse K, Nimura Y, Nakanishi M, and Sokabe M (2003) Stretch-induced IL-6 secretion from endothelial cells requires NF-kappaB activation. Biochem Biophys Res Commun 308:306-312. (Pubitemid 36937180)
13. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, and Kollias G (2001) Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 20:3760-3770. (Pubitemid 32691787)
14. Kumar S, Jiang MS, Adams JL, and Lee JC (1999) Pyridinylimidazole compound SB 203580. inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 263:825-831. (Pubitemid 29490712)
15. Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, and Kishimoto T (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98:346-352. (Pubitemid 28348057)
16. Mahmudi-Azer S, Velazquez JR, Lacy P, Denburg JA, and Moqbel R (2000) Immunofluorescence analysis of cytokine and granule protein expression during eosinophil maturation from cord blood-derived CD34 progenitors. J Allergy Clin Immunol 105:1178-1184. (Pubitemid 30418798)
17. Mann DL (1996) Stress activated cytokines and the heart. Cytokine Growth Factor Rev 7:341-354.
18. Matsushita K, Iwanaga S, Oda T, Kimura K, Shimada M, Sano M, Umezawa A, Hata J, and Ogawa S (2005) Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Lab Invest 85:1210-1223. (Pubitemid 41348637)
19. Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Selzman CH, Banerjee A, and Harken AH (1997) Alpha-adrenergic activation of myocardial NF kappa B during hemorrhage. J Surg Res 69:268-276. (Pubitemid 27317867)
20. Ming XF, Stoecklin G, Lu M, Looser R, and Moroni C (2001) Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol 21:5778-5789. (Pubitemid 32737795)
21. Pedersen BK and Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration and adaption. Physiol Rev 80:1055-1081. (Pubitemid 30452011)
22. 1D-adrenergic receptor cDNA. Mol Pharmacol 40:876-883.
23. 1C-adrenergic receptor provide evidence for its classification as the a1a-subtype. Mol Pharmacol 46:823-831. (Pubitemid 24984462)
24. 1B-adrenergic receptor. J Biol Chem 267: 21936-21945.
25. Rohrbach S, Engelhardt S, Lohse MJ, Werdan K, Holtz J, and Muller-Werdan U (2007) Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6. Mol Med 13:605-614. (Pubitemid 350228721)
26. Rorabaugh BR, Ross SA, Gaivin RJ, Papay RS, McCune DF, Simpson PC, and Perez DM (2005) alpha1A- but not alpha1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism. Cardiovasc Res 65:436-445. (Pubitemid 40082486)
27. Saucerman JJ, Zhang J, Martin JC, Peng LX, Stenbit AE, Tsien RY, and McCulloch AD (2006) Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes. Proc Natl Acad Sci U S A 103:12923-12928. (Pubitemid 44298662)
28. Sehgal PB, Grienger G, and Tosata G (1989) Regulation of the acute phase and immune responses: interleukin-6. Ann N Y Acad Sci 557:1-583.
29. Selvetella G, Hirsch E, Notte A, Tarone G, and Lembo G (2004) Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 63:373-380. (Pubitemid 38970181)
30. 1-adrenergic receptor signaling pathways: secreted factors and interactions with extracellular matrix. Mol Pharmacol 70:129-142. (Pubitemid 43920803)
31. Smart N, Mojet MH, Latchman DS, Marber MS, Duchen MR, and Heads RJ (2006) IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovasc Res 69:164-177. (Pubitemid 41814820)
32. Song DK, Im YB, Jung JS, Suh HW, Huh SO, Park SW, Wie MB, and Kim YH (1999) Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice. J Neurochem 72: 1625-1633. (Pubitemid 29140837)
33. Takaki A, Huang QH, Somogyva ri-Vigh A, and Arimura A (1994) Immobilisation stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1:335-342.
34. Tanda N, Ohyama H, Yamakawa M, Ericsson M, Tsuji T, McBride J, Elovic A, Wong DT, and Login GR (1998) IL-1 beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage, and release. Am J Physiol 274:G147-G156. (Pubitemid 28102937)
35. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, and Haegeman G (1998) p38 and extracellular signal-regulated kinase mitogenactivated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273:3285-3290. (Pubitemid 28109741)
36. Whitmarsh AJ, Shore P, Sharrocks AD, and Davis RJ (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
37. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Müller M, Gaestel M, Resch K, and Holtmann H (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18:4969-4980. (Pubitemid 29443799)
38. Zhao W, Liu M, and Kirkwood KL (2008) p38α stabilizes interleukin-6 mRNA via multiple AU-rich elements. J Biol Chem 283:1778-1785.
39. Zhong H, Lee D, Robeva A, and Minneman KP (2001) Signaling pathways activated by alpha1-adrenergic receptor subtypes in PC12 cells. Life Sci 68:2269-2276. (Pubitemid 32452382)
40. 1b-Adrenergic receptor causes apoptotic neurodegeneration: a multiple system atrophy. Nat Med 6:1388-1394. (Pubitemid 32001024)